BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• FDA

  TransEnterix Announces US 510(k) FDA Clearance for Senhance Surgical Robotic System

  TransEnterix, Inc., a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced the Company has received FDA 510(k) clearance for the Senhance Surgical Robotic System.

  October 14, 2017

   · 

  4 min read
• Business

  Bio-Rad To Report Third-Quarter 2017 Financial Results Thursday, November 2, 2017

  Bio-Rad Laboratories, Inc. will report financial results for the third quarter 2017 on Thursday, November 2, 2017, following the close of the market.

  October 14, 2017

   · 

  1 min read
• Biotech Beach

  NEMUS Provides Update on Previously Announced $20 Million Schneider Financing

  NEMUS Bioscience Provides Further Update on Previously Announced $20 Million Schneider Financing

  October 14, 2017

   · 

  3 min read
• 

  FDA

  Philips Wins FDA Nod for Small Parts Ultrasound Transducer

  Philips has received 510(k) clearance from the FDA to market the new eL18-4 transducer with full solution for ‘small parts’ assessment.

  October 14, 2017

   · 

  4 min read
• Business

  Otoharmonics Appoints Senior Vice President Of Sales

  Otoharmonics continues to expand its sales leadership team with the hire of Joel Ellis, Senior VP of Sales.

  October 14, 2017

   · 

  2 min read
• Business

  STYR Labs Appoints Pete Plamann As President To Bring High-Level Expertise In Consumer Engagement To Leadership Team

  STYR Labs announces the appointment of Pete Plamann as President. Plamann joins the STYR Labs leadership team, bringing high level development and implementation expertise to lead the company’s continued growth and aggressive expansion.

  October 14, 2017

   · 

  3 min read
• Policy

  GSK’s Shingrix Containing Agenus’ QS-21 Stimulon Adjuvant Receives Marketing Authorization From Health Canada

  Agenus announced today that Health Canada granted marketing authorization to Glaxo’s shingles vaccine, Shingrix, that contains Agenus’ proprietary immune adjuvant QS-21 Stimulon adjuvant.

  October 14, 2017

   · 

  4 min read
• Policy

  Orexigen Announces Favorable Decision From U.S. District Court In Patent Litigation, Confirming Exclusivity For Contrave Through 2030

  Orexigen announced today that the United States District Court for the District of Delaware issued a ruling in favor of Orexigen in the paragraph IV litigation against Actavis for three patents for Contrave (naltrexone HCl / bupropion HCl extended release) with exclusivity through 2030.

  October 14, 2017

   · 

  6 min read
• BioMidwest

  Aratana Therapeutics Announces Launch Of ENTYCE (Capromorelin Oral Solution)

  Aratana Therapeutics announced the Company is making ENTYCE (capromorelin oral solution) commercially available to veterinarians in the United States for appetite stimulation in dogs.

  October 14, 2017

   · 

  8 min read
• Deals

  Consortium Led By GL Capital Completes Acquisition Of SciClone

  SciClone and a consortium consisting of entities affiliated with GL Capital, BOCGI, CDH Investments, Ascendent Capital Partners and Boying today announced completion of the merger contemplated by the previously announced agreement and plan of merger, dated June 7, 2017.

  October 14, 2017

   · 

  8 min read